# China Pharma Holdings, Inc.: Form 8-K, filed Dec 21, 2023

- Company: [China Pharma Holdings, Inc.](/companies/cphi.md) (CIK 1106644)
- Form: 8-K
- Filed: 2023-12-21
- Accepted by EDGAR: Dec 21, 2023, 16:05 ET
- Period: 2023-12-15
- Accession: 0001213900-23-097680
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1106644/000121390023097680/ea190499-8k_chinapharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1106644/000121390023097680/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1106644/000121390023097680/ea190499-8k_chinapharma.htm

Filed Dec 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-097680. Last ingested by Listed: Nov 11, 2026, 00:23 ET. No prices; not investment advice.